Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2012 | 12-2011 | 12-2010 | 12-2009 | 12-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,091 | 3,467 | 5,278 | 3,430 | N/A |
| Receivables | 80 | 61 | 246 | N/A | N/A |
| TOTAL | $5,252 | $3,558 | $5,553 | $3,458 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 1,481 | 988 | 96 | 73 | N/A |
| Other Non-Current Assets | 49 | 23 | 38 | 23 | 0 |
| TOTAL | $1,530 | $1,011 | $134 | $96 | $N/A |
| Total Assets | $6,782 | $4,569 | $5,688 | $3,554 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 440 | 225 | 182 | 316 | 117 |
| Accrued Expenses | 145 | 135 | 222 | 37 | 1 |
| TOTAL | $584 | $359 | $604 | $353 | $117 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 200 | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $584 | $359 | $604 | $353 | $117 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 336,076 | 262,347 | 249,697 | 225,084 | 11,074 |
| Common Shares | 1 | 26 | 25 | 23 | 10 |
| Retained earnings | -10,950 | -6,105 | -2,869 | -1,060 | -118 |
| TOTAL | $6,197 | $4,210 | $5,084 | $3,201 | $-117 |
| Total Liabilities And Equity | $6,782 | $4,569 | $5,688 | $3,554 | $0 |